Haematologists recognised in Australia Day Honours
A number of haematologists and blood cancer researchers have been recognised for their contributions to the specialty in the 2023 Australia Day Honours. Clinical Professor Graham Lieschke was made a Member of the Order of Australia (AM) for his “significant service to medicine as a haematologist, and to medical research”. The accolade...
CAR-T in Practice - ALL workshop
Join online as a panel of experts explore the practicalities and management challenges of CAR-T therapy for adult and paediatric ALL patients via a varied series of case presentations. Hosted by Associate Professor Shaun Fleming. Head of Myeloid...
ASH 2022: Highlights through an Australian lens - dinner meetings
Join the limbic and expert panels in Sydney, Melbourne and Brisbane as they present the best from the ASH 2022 Annual Meeting and discuss the impacts for patient care. SYDNEY Tuesday 14th February, 7:00pm...
Lipid levels may influence growth of leukaemias
Lipid levels may play a key role in the growth of cancer cells that have IDH1 gene mutations such as in acute myeloid leukaemia, researchers from South Australia have found. The findings suggest that a low fat diet or lipid-lowering medications...
Lipid levels may play a key role in the growth of cancer cells that have IDH1 gene mutations such as...
LaRDR registry reveals clinical characteristics of Australian patients with classical Hodgkin Lymphoma
Baseline demographics and early outcome data from classical Hodgkin lymphoma (cHL) cases in the Lymphoma and Related Diseases Registry (LaRDR) are consistent with that of other international registries. Data from 498 eligible patients registered across 23 sites in Australia between July...
Baseline demographics and early outcome data from classical Hodgkin lymphoma (cHL) cases in the Lymphoma and Related Diseases Registry (LaRDR)...
BMI extremes linked with worse MM survival
BMI is a risk factor for survival in patients newly diagnosed with multiple myeloma, new research shows. Data from 1,120 patients (61% male, median age 63) in the US Multiple Myeloma Research Foundation CoMMpass registry revealed that...
BMI is a risk factor for survival in patients newly diagnosed with multiple myeloma, new research shows. ...